• Explore /
  • Poster
  • / Evaluation of tumor genomic variants in Japanese patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide: Protocol of a phase 4 study (CUARTET).

Evaluation of tumor genomic variants in Japanese patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide: Protocol of a phase 4 study (CUARTET).

Abstract Video & Slides Poster

Authors

null

Hirotsugu Uemura

Department of Urology, Kindai University Hospital, Osakasayama, Japan

Hirotsugu Uemura , Toshiyuki Kamoto , Hiroji Uemura , Naoya Masumori , Naoki Terada , Shusuke Akamatsu , Yosuke Koroki , Shintaro Ono , Miku Ito , Hideyasu Matsuyama

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04601441

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS196)

DOI

10.1200/JCO.2022.40.6_suppl.TPS196

Abstract #

TPS196

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Guillaume Grisay

First Author: Sachdev P. Thomas

First Author: Alyssa Liang

First Author: Earle Frederick Burgess